SINCE 2011
For 20+ years, most believed we had only a few hours after a stroke to provide treatment—but the RapidAI founders were never satisfied with that thinking. They theorized that stroke evolution was highly variable, the conventional short treatment windows could be upended, and far more people with cerebrovascular disorders could be saved. They recognized that technology was the limiting factor even after an early NIH-funded, multicenter trial showed important advancements. The founders developed the Rapid platform to address this need.
Leadership
Don Listwin
President & CEO
Dr. Greg Albers
Co-founder & Scientific Lead
Roland Bammer
Co-founder & Technical Lead
Success Stories
CLIENTS:
1,600+
hospitals
PARTNERSHIPS:
Business
BUSINESS MODEL:
Annual License
INVESTMENTS:
$25 million
Series B
Solutions
AREA OF
EXPERTISE:
Brain
CURRENT SOLUTIONS:
Rapid, its cerebrovascular imaging software platform powered by artificial intelligence, currently includes:
- Rapid ICH
Automatically triages non-contrast CT scans to quickly identify suspected intracranial hemorrhages - Rapid ASPECTS
Automatically identifies areas of early ischemic change on non-contrast CT scans, which predicts irreversible injury; the first and only neuro-imaging device which has been shown to improve reader diagnosis under the FDA’s CADx (Computer-Assisted Diagnostic) classification - Rapid CTA and Rapid LVO
Automatically assesses regions of reduced blood flow to identify, locate, and alert stroke teams to the presence of suspected large vessel occlusions (LVOs) - Rapid CTP
Fully-automated perfusion maps; accurately quantifies reduced cerebral blood flow, cerebral blood volume and transit time; the only clinically validated software with an FDA indication to aid in the selection of patients for acute stroke therapy - Rapid MRI
Fully-automated diffusion and perfusion maps that quantify brain areas with low ADC values, as well as delayed contrast arrival - Rapid Mobile App
Securely access RapidAI results and preview source files from multiple sites, receive notifications, and communicate about patient care, anytime, anywhere - SurgicalPreview
A cloud-based computational platform providing comprehensive cerebral aneurysm management—automating the entire workflow from initial assessment to growth monitoring and treatment planning - Rapid Web App
Conveniently view new case information and preview Rapid results using Google Chrome or Microsoft Edge on any desktop or laptop—saving you and your patients precious time - RapidAI Insights
A suite of reports and analytics on Rapid scan, treatment and outcomes data that help hospital clinical, executive and IT teams make informed decisions to standardize stroke care processes and optimize operational efficiencies
Modalities Covered
MRI
CT
X-RAY
ULTRASOUND
PET SCAN
DIGITAL
MAMMOGRAPHY
Step of the Radiologist Journey
Brief History
Vision for the Future
WHAT IS YOUR
PRODUCT DEVELOPMENT ROADMAP?
In 2020, RapidAI expanded its scope from ischemic stroke to hemorrhagic stroke and comprehensive aneurysm management.
HOW DO YOU SEE THE FUTURE
OF THE AI ECOSYSTEM?
Already a key component in advanced medical imaging, AI will continue to expand its use across serious conditions and stages of diagnosis and treatment.
WHAT IS YOUR ROLE IN IT?
The Rapid platform is the de facto standard in cerebrovascular imaging and the company is the trailblazer in utilizing machine learning and artificial intelligence to empower clinicians to make faster, more accurate diagnostic and treatment decisions—ultimately improving patient outcomes. RapidAI will continue to expand AI’s use from improving the capabilities of readers of scans to expanded use in tracking and treating.
Ai radiology startup
universe
Get your exclusive FREE access to some of the fastest growing Ai Radiology start ups NOW!
